Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Antimicrobial Resistance

    Antibiotic Resistant Bacteria Countermeasure Accelerator

    By Global Biodefense StaffFebruary 23, 2016
    Ebola Drug Research at UTMB
    Share
    Facebook LinkedIn Reddit Email

    A new federal grant opportunity supporting a ‘Combating Antibiotic Resistant Bacteria (CARB) Biopharmaceutical Accelerator’ initiative has been issued by the U.S. Department of Health and Human Services Assistant Secretary for Preparedness and Response (HHS/ASPR).

    The program is a novel collaborative model designed to spur innovation and investment towards new antimicrobial products to repopulate the early development pipeline, and is a component of the National Strategy for Combating Antimicrobial Resistant Bacteria.

    Candidates that graduate from the Accelerator will be better positioned for R&D investment and clinical development.

    This Accelerator for CARB will be focusing only on antibacterial products, working in tandem with the medical countermeasure accelerator efforts of Biomedical Advanced Research and Development Authority (BARDA) and National Institute of Allergy and Infectious Diseases (NIAID).

    BARDA will provide direct funding and NIAID will provide in-kind services (e.g. preclinical services, technical expertise) to Accelerator grant recipients.

    Further details are available via Funding Opportunity Number: EP-IDS-16-001. The closing date for applications is April 15, 2016

    Antimicrobials ASPR BARDA HHS MRSA Request for Proposals
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleEPFL’s Portable Rapid Microfluidic Device
    Next Article DTRA Extends MRIGlobal Mobile Lab Support in West Africa

    Related Stories

    EPA Developing AMR Risk Framework for Antibacterial and Antifungal Pesticides

    September 29, 2023

    Provide Feedback on Federal DURC Biosafety Oversight of Potential Pandemic Pathogens

    September 24, 2023

    Committee to Examine Transmission and Geographic Spread of Chronic Wasting Disease

    September 24, 2023

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy